WORLD BIO SUMMIT 2023

PROGRAM

Program on November 21

09:00 ~

11:00 

SESSION 2. Accelerating Pandemic Therapeutics Development and Manufacturing

Park Ballroom5F


13:00 ~

15:00

SESSION 3. International Support Strategies for  the  Growth of the Global In Vitro Diagnostics Industry and South Korea's Role

Park Ballroom

5F


15:20 ~

17:20

SESSION 4. Strengthening Global Preparedness Through CEPI’s 100-Day Mission

Grand Ballroom 3F


17:30 ~

18:00


Closing Ceremony

Grand Ballroom 3F


[SESSION 2] Accelerating Pandemic 
Therapeutics Development and Manufacturing
21(Tue) November
09:00~11:00
Park Ballroom, 5F

During the global public health crisis caused by COVID-19 pandemic, some countries and bio industries have developed therapeutics in a short period. After COVID-19, a worldwide consensus was created that efforts to strengthen technological innovation and global cooperation throughout the development, production, and supply of pharmaceuticals are necessary. 


In order to delay the spread of emerging infectious diseases, timely development, manufacturing and supply of therapeutics is important, and international efforts and cooperation are needed to implement them. Under the title “Accelerating pandemic therapeutics development and manufacturing”, the participants consist of various fields including governments, international organizations, international foundations and global experts as well as bio industries representative will present the future strategies and visions related to emerging infectious disease therapeutics and share policies on global investment for next-pandemic preparedness.

09:00~09:10
Opening Ceremony

Hee-Chang Jang

Director General, 

Korean National Institute of Infectious Disease(NIID)

09:10~09:20
Introduction of Speakers,
Panels and Session Contents

Laurent Muschel

Acting Director-General, 

European Health Emergency Preparedness 

and Response Authority

09:20~09:50
Strengthening Capacities 
for Pandemic Infectious 
Diseases Response

Carmen Pérez Casas

Senior Strategy Lead and Head of PPPR

(Pandemic Prevention, Preparedness and Response),

Unitaid


Jicui Dong 

Unit Head of Local Production & Assistance, RPQ, 

World Health Organization(WHO)

09:50~10:30
Next Pandemic
Preparedness: 
The Recent Trends for 
Therapeutics Development, 
Manufacturing 
and Supply Diversified 
Strategy for Global 
Therapeutics Research 
Cooperation

Hyunsang Muk

President & CEO, 

Korea Drug Development Fund (KDDF) Foundation


Seamus O'Brien

R&D Director, Global Antibiotic Research & Development Partnership (GARDP)


Soo Young Lee

Senior Vice President, Celltrion Inc.


Petro Terblanche

CEO, Afrigen Biologics

10:30~10:50
Global Cooperation
for Accelerating 
The Therapeutics 
Development and 
Strengthening Capacities

[Moderator]

Laurent Muschel

Acting Director-General, 

European Health Emergency Preparedness 

and Response Authority


[Panels]

Hayato Urabe

Associate Vice President, 

Global Health Innovative Technology(GHIT) Fund


Carmen Pérez Casas

Senior Technical Manager and Head of PPPR, UNITAID


Jicui Dong 

Unit Head of Local Production & Assistance, RPQ, 

World Health Organization(WHO)


Hyunsang Muk

President & CEO, 

Korea Drug Development Fund (KDDF) Foundation


Seamus O'Brien

R&D Director, 

Global Antibiotic Research & Development Partnership (GARD-P) 


Soo Young Lee

Senior Vice President, Celltrion Inc.


Petro Terblanche

CEO, Afrigen Biologics

10:50~11:00
Closing Remarks

Laurent Muschel

Acting Director-General, 

European Health Emergency Preparedness 

and Response Authority

[ SESSION 3 ] International Support 
Strategies for  the  Growth of the Global 
in Vitro Diagnostics Industry and South Korea's Role
 21(Tue) November
13:00~15:00
Park Ballroom, 5F

Amidst the ongoing winding down of the COVID-19 pandemic, the approval of the agenda item focused on enhancing global health capacity in the field of diagnostics at the 76th World Health Assembly in May 2023 has prompted the need for discussions on how key stakeholders can support implementation of this Resolution. In this context, it is necessary to consider the direction that South Korea will take. Notably, South Korea’s proactive establishment of nationwide COVID-19 diagnostic testing through close collaboration between the government, industry, relevant academic societies, and other stakeholders has garnered attention globally. As the world looks ahead to response to future infectious diseases, there is growing interest in South Korea's role. Furthermore, South Korea's strengths in the field of diagnostic testing are recognized internationally for their potential to significantly contribute to strengthening future infectious disease response systems and enhancing global health equity. Consequently, there is an increasing awareness of the role South Korea can play on the global stage. Having successfully responded to disease outbreaks through effective diagnostics, South Korea is poised to explore the expectations placed on it within the global healthcare system. In summary, as the world transitions from the COVID-19 pandemic, discussions are needed to explore South Korea's expected role in the global healthcare landscape, considering its successful use of diagnostics to respond to infectious diseases, its potential in the diagnostic testing industry, and its potential to contribute to global health equity and preparedness efforts.

13:00∼13:10
Congratulatory Remarks
Youk Sambath

Secretary of State, Ministry of Health,

Kingdom of Cambodia

13:10~13:30
The Significance of Diagnostic Devices in Future Global Health and Infectious Disease Response Systems
Willo Brock 

Executive Vice President, External Affairs, FIND

13:10~13:20
NextGen Market Shaping 
Approach and the Growing 
Role of Diagnostics 
Hui Yang

Head of Supply Operations, The Global Fund

13:20~13:30
Global Trends in the 
Utilization of AI Technology in Diagnostic Devicess
Ricardo Baptista Leite 

CEO, HealthAI 

13:30~13:40
Strengthening Diagnostics
Capacity in the Context of the WHA Resolution on Diagnostics

Catharina Boehme

Assistant Director-General, External Relations and Governance, World Health Organization(WHO)

13:40~14:05
Korea’s Role in Strengthening Global Diagnostic Capacity 
[Moderator] 

Hoon Sang Lee

CSO, 

Research Investment for Global Health Technology

(RIGHT) Foundation


Catharina Boehme

Assistant Director-General, External Relations and Governance, World Health Organization(WHO)


Marta Fernández Suárez

Chief Technology Officer, FIND


Nqobile Ndlovu

CEO, Africa Society of Laboratory Medicine(ASLM) 


Sang Won Lee 

Director, Infectious Disease Diagnosis and Analysis, 

Korea Disease Control and Prevention Agency(KDCA)

14:05~14:15
Strategies for Enhancing 
Quality in IVDs 
Seung Yong Lee 

Director, 

Innovative & Diagnostic Device Policy Division, Ministry of Food and Drug Safety(MFDS)

14:15~14:25 
International Collaboration
Strategies for Diagnostic 
Testing Systems
Yeo Min Yun 

Director of Scientific Affairs,

Korean Society of Laboratory Medicine (KSLM)

14:25~14:45
Cases of Collaboratin
(Technology Transfer, training etc)
[Moderator] 

Sung Eun Hwang

Director, Department of Medical Device Industry,

Korea Health Industry Development Institute(KHIDI)  


[Panels]

Seung Yong Lee

Director, Innovative & Diagnostic Device Policy Division, Ministry of Food and Drug Safety(MFDS)


Yeo Min Yun

Director of Scientific Affairs,

Korean Society of Laboratory Medicine (KSLM)


Han-Oh Park

Founder, CEO & Chairman, BIONEER Corporation


Seong Youl Kim

Senior Vice President, Global Marketing Center,

Seegene Inc.

14:45~15:00
Closing Remarks
Willo Brock

Executive Vice President, External Affairs, FIND

[ Session4 ] Strengthening Global Preparedness Through CEPI’s 100-Day Mission
21(Tue) November
15:20~17:20
Grand Ballroom, 3F

The primary objective of this plenary session is to discuss and strategize the implementation of CEPI's 100 days mission to respond swiftly and effectively to epidemic and pandemic infectious diseases threats.


This mission will foster collaboration among key stakeholders, including industry, academia, governments, and international organizations. The session aims to present the mission and gather support and commitment from various stakeholders.

15:20~15:25
Opening Remarks

In-Kyu Yoon

Director Programmes and Innovative Technology, 

Coalition for Epidemic Preparedness Innovations(CEPI)

15:25~15:40
CEPI's 100-Day Mission

A Paradigm Shift: 

What Will It Take and 

What is needed to Speed Up 

Vaccine Development Through Crucial Scientific 

and Technological Innovations

Jane Halton

Chair of CEPI Board,

Coalition for Epidemic Preparedness Innovations(CEPI)

15:40~15:55
CEPI's Collaboration with 
International Vaccine Institute (IVI) 

Jerome H. Kim

Director General,  International Vaccine Institute(IVI) 

15:55~16:10
Collaboration with Korea 
Disease Control and 
Prevention Agency (KDCA) 

Gi-eun Rhie 

Director General, Center for Vaccine Research(CVR),

Korea Disease Control and Prevention Agency(KDCA) 

16:10~16:20
Contribution for Public Health System with CEPI 

Emanuele Montomoli

President and CSO of Vismederi

16:20~16:30
Collaboration with Industry: 
Biofarma, Indonesian Vaccine Manufacturer

Shadiq Akasya 

President Director, Bio Farma

16:30~16:40
Collaboration with Industry: 
SK bioscience

Jin S. Park

Senior Vice President and Head of BD, SK bioscience

16:40~16:50
Engagement with Academia 

Trent Munro

Industry Professor & Group Leader Australian Institute for Bioengineering & Nanotechnology (AIBN), 

University of Queensland 

16:50~17:10
Roundtable Discussion 

Challenges in Global Preparedness

Identify the Key Challenges Faced by the Global Community 

in Terms of Preparedness for Health Crises. 


Strategies and Initiatives 

Delve into the Strategies and Initiatives that 

CEPI is Implementing

to Address these 

Challenges Within the 100-day Mission. 


Collaborative Opportunities 

Explore Potential Areas for Collaboration

and Partnerships with Other Organizations, 

Governments, and 

Stakeholders. 

[Moderator] 

Kate Kelland 

Chief Scientific Writer,

Coalition for Epidemic Preparedness Innovations(CEPI)


[Panels] 

Trent Munro

Industry Professor&Group Leader Australian Institute for Bioengineering & 

Nanotechnology (AIBN), 

University of Queensland 


Emanuele Montomoli

President and CSO 

of Vismederi


Shadiq Akasya 

President Director, 

Bio Farma


Jin S. Park

Senior Vice President and Head of BD, 

SK bioscience


17:10~17:20
Closing Remarks

(Conclusion & Group Photo)

Jerome H. Kim

Director General,  International Vaccine Institute(IVI)


Jane Halton

Chair of CEPI Board,

Coalition for Epidemic Preparedness Innovations(CEPI)

CLOSING CEREMONY
21(Tue) November
17:30~18:00
Grand Ballroom, 3F

In the final session of the two-day WORLD BIO SUMMIT 2023, we will revisit discussed strategies and global cooperation for the next pandemic response, a model of regional hubs for biomanufacturing and R&D to enhance access to infectious disease countermeasures in LMICs, and global health security through the cooperation of businesses, societies, international organization, and governments. In order to prevent, prepare, and respond better to the next pandemic, the international community, international organizations and the private sector need to stand up together, set optimal investment strategies for technological innovation in vaccine and bio health, and promote coordinated international cooperation based on the solidarity of allowing no one, no country, and no region to be left behind.

17:30~17:32
Moderator

Isabel Oliver

CSO and Director General Science and Research, 

UK Health Security Agency

17:32~17:52
Session-Specific Briefings

Patrick Osewe

Director-Health, Human and Social Development Sector Office, Asian Development Bank(ADB)

Laurent Muschel

Acting Director-General, 

European Health Emergency Preparedness 

and Response Authority

Willo Brock

Executive Vice President, External Affairs, FIND

Jane Halton

Chair of CEPI Board,

Coalition for Epidemic Preparedness Innovations(CEPI)

Kate Kelland

Chief Scientific Writer,

Coalition for Epidemic Preparedness Innovations(CEPI)

17:52~17:55

A video of photos from 

the summit

17:55~18:00
Closing Remarks

Min Soo Park

Vice Minister, Ministry of Health and Welfare, 

Republic of Korea


Program on November 21


09:00~11:00

SESSION 2. Accelerating Pandemic Therapeutics                                       Development and Manufacturing

Park Ballroom, 5F

13:00~15:00

SESSION 3. International Support Strategies for the 

                    Growth of the Global In Vitro Diagnostics                                 Industry and South Korea's Role

Park Ballroom, 5F

15:20~17:20


SESSION 4. Strengthening Global Preparedness
                    Through CEPI’s 100-Day Mission
Grand Ballroom, 3F

17:30~18:00

Closing Ceremony
Grand Ballroom, 3F
[SESSION 2] Accelerating Pandemic Therapeutics Development and Manufacturing
Tuesday, November 21, 09:00 – 11:00   I   Park Ballroom, 5F


During the global public health crisis caused by COVID-19 pandemic, some countries and bio industries have developed therapeutics in a short period. After COVID-19, a worldwide consensus was created that efforts to strengthen technological innovation and global cooperation throughout the development, production, and supply of pharmaceuticals are necessary. 


In order to delay the spread of emerging infectious diseases, timely development, manufacturing and supply of therapeutics is important, and international efforts and cooperation are needed to implement them. Under the title “Accelerating pandemic therapeutics development and manufacturing”, the participants consist of various fields including governments, international organizations, international foundations and global experts as well as bio industries representative will present the future strategies and visions related to emerging infectious disease therapeutics and share policies on global investment for next-pandemic preparedness.


Time
Program
Speaker
09:00~09:10
Opening Remarks
Hee-Chang Jang

Director General,

Korean National Institute of Infectious Disease(NIID)

09:10~09:20
Introduction of Speakers, 
Panels and Session Contents

Laurent Muschel

Acting Director-General,
European Health Emergency Preparedness 
and Response Authority
09:20~09:50
Strengthening Capacities 
for Pandemic Infectious Diseases Response

Carmen Pérez Casas

Senior Strategy Lead and Head of PPPR

(Pandemic Prevention, Preparedness and Response), Unitaid


Jicui Dong

Unit Head of Local Production & Assistance, RPQ, 

World Health Organization(WHO)

09:50~10:30
Next Pandemic Preparedness:
The Recent Trends for Therapeutics Development,
Manufacturing and Supply 
Diversified Strategy for Global 
Therapeutics Research Cooperation

Hyunsang Muk

President & CEO, 

Korea Drug Development Fund (KDDF) Foundation


Seamus O'Brien

R&D Director,

Global Antibiotic Research & Development Partnership (GARD-P)


Soo Young Lee

Senior Vice President, Celltrion Inc.


Petro Terblanche

CEO, Afrigen Biologics
10:30~10:50
Global Cooperation for Accelerating 
the Therapeutics Development
and Strengthening Capacities

[Moderator]

Laurent Muschel

Acting Director-General,
European Health Emergency Preparedness 
and Response Authority


[Panels] 

Hayato Urabe

Associate Vice President,
Global Health Innovative Technology Fund(GHIT FUND)


Carmen Pérez Casas

Senior Strategy Lead and Head of PPPR

(Pandemic Prevention, Preparedness and Response), Unitaid


Jicui Dong

Unit Head of Local Production & Assistance, RPQ, 

World Health Organization(WHO)


Hyunsang Muk

President & CEO, 
Korea Drug Development Fund (KDDF) Foundation


Seamus O'Brien

R&D Director, 

Global Antibiotic Research & Development Partnership (GARD-P)


Soo Young Lee

Senior Vice President, Celltrion Inc.


Petro Terblanche

CEO, Afrigen Biologics
10:50~11:00
Closing Remarks

Laurent Muschel

Acting Director-General,
European Health Emergency Preparedness 
and Response Authority

* The time and content are subject to change.

[SESSION 3] International Support Strategies for the Growth of the Global in Vitro Diagnostics Industry 
                           and South Korea's Role
Tuesday, November 21, 13:00 – 15:00   I   Park Ballroom, 5F


Amidst the ongoing winding down of the COVID-19 pandemic, the approval of the agenda item focused on enhancing global health capacity in the field of diagnostics at the 76th World Health Assembly in May 2023 has prompted the need for discussions on how key stakeholders can support implementation of this Resolution. In this context, it is necessary to consider the direction that South Korea will take. Notably, South Korea’s proactive establishment of nationwide COVID-19 diagnostic testing through close collaboration between the government, industry, relevant academic societies, and other stakeholders has garnered attention globally. As the world looks ahead to response to future infectious diseases, there is growing interest in South Korea's role.


Furthermore, South Korea's strengths in the field of diagnostic testing are recognized internationally for their potential to significantly contribute to strengthening future infectious disease response systems and enhancing global health equity. Consequently, there is an increasing awareness of the role South Korea can play on the global stage. Having successfully responded to disease outbreaks through effective diagnostics, South Korea is poised to explore the expectations placed on it within the global healthcare system.


In summary, as the world transitions from the COVID-19 pandemic, discussions are needed to explore South Korea's expected role in the global healthcare landscape, considering its successful use of diagnostics to respond to infectious diseases, its potential in the diagnostic testing industry, and its potential to contribute to global health equity and preparedness efforts.


Time
Program
Speaker
13:00∼13:05
Congratulatory Remarks
Youk Sambath
Secretary of State, Ministry of Health, 
Kingdom of Cambodia
13:05 - 13:10
The Significance of Diagnostic Devices in Future Global Health and Infectious Disease Response Systems
Willo Brock
Executive Vice President, External Affairs, FIND
13:10 - 13:20
NextGen Market Shaping Approach and 
the Growing Role of Diagnostics 

Hui Yang

Head of Supply Operations, The Global Fund

13:20 - 13:30
Global Trends in the Utilization of AI Technology in Diagnostic Devices

Ricardo Baptista Leite

CEO, HealthAI 

13:30 - 13:40
Strengthening Diagnostics Capacity in the 
Context of the WHA Resolution on Diagnostics

Catharina Boehme

Assistant Director-General, External Relations and Governance, World Health Organization(WHO)

13:40 - 14:05

Korea’s Role in Strengthening Global Diagnostic Capacity

[Moderator] 

Hoon Sang Lee 

CSO, Research Investment for Global Health Technology(RIGHT) Foundation


[Panels]

Catharina Boehme

Assistant Director-General, External Relations and Governance, World Health Organization(WHO)


Marta Fernández Suárez
Chief Technology Officer, FIND


Nqobile Ndlovu

CEO, Africa Society of Laboratory Medicine(ASLM)


Sang Won Lee

Director, Infectious Disease Diagnosis and Analysis, 

Korea Disease Control and Prevention Agency(KDCA)

14:05 - 14:15
Strategies for Enhancing Quality in IVDs

Seung Yong Lee

Director, Innovative & Diagnostic Device Policy Division,

Ministry of Food and Drug Safety(MFDS)

14:15 - 14:25
International Collaboration Strategies for 
Diagnostic Testing Systems

Yeo Min Yun

Director of Scientific Affairs,
Korean Society of Laboratory Medicine (KSLM)

14:25 - 14:50
Cases of Collaboration
(Technology Transfer, Training etc)

[Moderator] 

Sung Eun Hwang

Director, Department of Medical Device Industry,

Korea Health Industry Development Institute(KHIDI) 


[Panels]

Seung Yong Lee

Director, Innovative & Diagnostic Device Policy Division, Ministry of Food and Drug Safety(MFDS)


Yeo Min Yun

Director of Scientific Affairs,
Korean Society of Laboratory Medicine (KSLM)


Han-Oh Park

Founder, CEO & Chairman, BIONEER Corporation


Seong Youl Kim

Senior Vice President, Global Marketing Center, Seegene Inc.

14:50 - 15:00
Closing Remarks
Willo Brock
Executive Vice President, External Affairs, FIND

* The time and content are subject to change.

[SESSION 4] Strengthening Global Preparedness through CEPI’s 100-Day Mission
Tuesday, November 21, 15:20 – 17:20   I   Grand Ballroom, 3F


The primary objective of this plenary session is to discuss and strategize the implementation of CEPI's 100 days mission to respond swiftly and effectively to epidemic and pandemic infectious diseases threats.

This mission will foster collaboration among key stakeholders, including industry, academia, governments, and international organizations. The session aims to present the mission and gather support and commitment from various stakeholders.


Time
Program
Speaker
15:20~15:25
Opening Remarks
In-Kyu Yoon
Director Programmes and Innovative Technology, 
Coalition for Epidemic Preparedness Innovations(CEPI)
15:25~15:40
CEPI's 100-Day Mission
A Paradigm Shift: 
What will it take and What is Needed to Speed Up 
Vaccine Development Through Crucial Scientific 
and Technological Innovations

Jane Halton 

Chair of CEPI Board,

Coalition for Epidemic Preparedness Innovations(CEPI)
15:40~15:55
CEPI's Collaboration 
with International Vaccine Institute (IVI)

Jerome H. Kim 

Director General,  International Vaccine Institute(IVI)

15:55~16:10
Collaboration 
with Korea Disease Control and Prevention Agency (KDCA)

Gi-eun Rhie 

Director General, Center for Vaccine Research(CVR),

Korea Disease Control and Prevention Agency(KDCA)

16:10~16:20
Contribution for Public Health System with CEPI

Emanuele Montomoli

President and CSO of Vismederi, 

University of Siena & VisMederi

16:20~16:30
Collaboration with Industry: Bio Farma, 
Indonesian Vaccine Manufacturer

Shadiq Akasya 

President Director, Bio Farma

16:30~16:40
Collaboration with Industry: SK bioscience

Jin S. Park

Senior Vice President and Head of BD, SK bioscience

16:40~16:50
Engagement with Academia

Trent Munro

Industry Professor & Group Leader Australian Institute for Bioengineering & Nanotechnology (AIBN), 

University of Queensland

16:50~17:10
Roundtable Discussion 

Challenges in Global Preparedness 
Identify the Key Challenges Faced by the Global Community in Terms of Preparedness for Health Crises

Strategies and Initiatives 
Delve into the Strategies and Initiatives that 
CEPI is Implementing to Address 
These Challenges within the 100-day Mission


Collaborative Opportunities
Explore Potential Areas for Collaboration and Partnerships 
with Other Organizations, Governments, and Stakeholders

[Moderator] 

Kate Kelland

Chief Scientific Writer, 

Coalition for Epidemic Preparedness Innovations(CEPI)


[Panels]

Trent Munro  

Industry Professor & Group Leader Australian Institute for Bioengineering & Nanotechnology (AIBN), 

University of Queensland 


Emanuele Montomoli

President and CSO of Vismederi, 

University of Siena & VisMederi


Shadiq Akasya 

President Director, Bio Farma


Jin S. Park

Senior Vice President and Head of BD, SK bioscience

17:10~17:20
Closing Remarks

(Conclusion Group Photo)

Jerome H. Kim 

Director General,  International Vaccine Institute(IVI)


Jane Halton 

Chair of CEPI Board,

Coalition for Epidemic Preparedness Innovations(CEPI)

* The time and content are subject to change.

CLOSING CEREMONY
Tuesday, November 21, 17:30 – 18:00   I   Grand Ballroom, 3F


In the final session of the two-day WORLD BIO SUMMIT 2023, we will revisit discussed strategies and global cooperation for the next pandemic response, a model of regional hubs for biomanufacturing and R&D to enhance access to infectious disease countermeasures in LMICs, and global health security through the cooperation of businesses, societies, international organization, and governments. In order to prevent, prepare, and respond better to the next pandemic, the international community, international organizations and the private sector need to stand up together, set optimal investment strategies for technological innovation in vaccine and bio health, and promote coordinated international cooperation based on the solidarity of allowing no one, no country, and no region to be left behind.


Time
Program
Speaker
17:30∼17:32
Introduction of Speakers, 
Panels and Session Contents
Isabel Oliver

CSO and Director General Science and Research, 

UK Health Security Agency

17:32~17:52

Session-Specific Briefings

Patrick Osewe

Director-Health, Human and Social Development Sector Office, Asian Development Bank(ADB)

 Laurent Muschel

Acting Director-General,

European Health Emergency Preparedness

and Response Authority

Willo Brock
Executive Vice President, External Affairs, FIND

Jane Halton 

Chair of CEPI Board,

Coalition for Epidemic Preparedness Innovations(CEPI)


Kate Kelland

Chief Scientific Writer, 

Coalition for Epidemic Preparedness Innovations(CEPI)

17:52~17:55


A video of photos from the summit

17:55~18:00
Closing Remarks

Min Soo Park

Vice Minister, Ministry of Health and Welfare,

Republic of Korea

* The time and content are subject to change.



WORLD BIO SUMMIT 2023 Secretariat

E-mail: worldbiosummit@korea.kr

@Copyright WORLD BIO SUMMIT 2023. All Right Reserved.